As of 2026-05-28, the Fair Value of Gene One Life Science Inc (011000.KS) is -3,699.50 KRW. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1,296.00 KRW, the upside of Gene One Life Science Inc is -385.46%.
With the market price of 1,296.00 KRW and our fair value calculation, Gene One Life Science Inc (011000.KS) is not a good investment. Investing in 011000.KS stocks now will result in a potential loss of 385.46%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -15,887.89 | -38,150.07 | -77,768.04 | -48,536.61 | -51,850.98 | -46,438.72 |
| YoY growth | 14.80% | -140.12% | -103.85% | 37.59% | -6.83% | -39.68% |
| Market Cap (mil) | 90,821.61 |
| P/E | |
| Forward P/E |
| EPS | -739.90 |
| Avg earnings growth rate | -39.68% |
| TTM earnings | -51,850.98 |